• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经 75%乙醇蒸气处理的再生丝素蛋白纳米纤维基质,可用于组织工程应用。

Regenerated silk fibroin nanofibrous matrices treated with 75% ethanol vapor for tissue-engineering applications.

机构信息

Key Laboratory of Textile Science and Technology Ministry of Education, Donghua University, Shanghai 201620, P. R. China.

出版信息

J Biomater Sci Polym Ed. 2012;23(1-4):497-508. doi: 10.1163/092050610X552771. Epub 2011 Jan 28.

DOI:10.1163/092050610X552771
PMID:21294970
Abstract

As an excellent biocompatible and biodegradable protein polymer, silk fibroin (SF) has found wide applications, particularly serving as therapeutic agent for tissue-engineering applications, on which both post-spin treatment and sterilization processing are crucial to drug-loaded matrices. To find a safe, effective and appropriate post-spin treatment and sterilization approach for drug-loaded biomaterial matrices is one of the major problems in the field of tissue engineering at present. In this work, a simple, safe and effective approach skillfully integrating post-spin treatment with sterilization processing was developed to drug-loaded SF nanofibrous matrices. Electrospun SF nanofibrous matrices from its aqueous solution were post-treated with 75% ethanol vapor. (13)C-NMR and WAXD analysis demonstrated that such post-spin treatment rendered the structure of SF nanofibrous matrices transform from the silk I form to the silk II form. Furthermore, biological assays suggested that as-treated SF nanofibrous matrices significantly promoted the development of murine connective tissue fibroblasts. Skillfully integrated with novel sterilization processing, 75% ethanol vapor treatment could be a potential approach to designing and fabricating diverse drug-loaded SF nanofibrous matrices serving as therapeutic agents for tissue-engineering applications in that it can effectively protect the drug from losing compared with traditional post-spin treatment and sterilization processing.

摘要

作为一种优秀的生物相容性和可生物降解的蛋白质聚合物,丝素(SF)已经得到了广泛的应用,特别是作为组织工程应用的治疗剂,其纺丝后处理和灭菌处理对于载药基质都至关重要。寻找一种安全、有效和合适的载药生物材料基质的纺丝后处理和灭菌方法是当前组织工程领域的主要问题之一。在这项工作中,开发了一种简单、安全、有效的方法,巧妙地将纺丝后处理与灭菌处理结合起来,用于载药 SF 纳米纤维基质。从丝素水溶液中电纺的 SF 纳米纤维基质用 75%乙醇蒸汽进行后处理。(13)C-NMR 和 WAXD 分析表明,这种纺丝后处理使 SF 纳米纤维基质的结构从丝素 I 型转变为丝素 II 型。此外,生物分析表明,经处理的 SF 纳米纤维基质显著促进了鼠结缔组织成纤维细胞的发育。巧妙地与新型灭菌处理相结合,75%乙醇蒸汽处理可能是设计和制造各种用作组织工程应用治疗剂的载药 SF 纳米纤维基质的潜在方法,因为与传统的纺丝后处理和灭菌处理相比,它可以有效地保护药物不流失。

相似文献

1
Regenerated silk fibroin nanofibrous matrices treated with 75% ethanol vapor for tissue-engineering applications.经 75%乙醇蒸气处理的再生丝素蛋白纳米纤维基质,可用于组织工程应用。
J Biomater Sci Polym Ed. 2012;23(1-4):497-508. doi: 10.1163/092050610X552771. Epub 2011 Jan 28.
2
Collagen-based biomimetic nanofibrous scaffolds: preparation and characterization of collagen/silk fibroin bicomponent nanofibrous structures.基于胶原蛋白的仿生纳米纤维支架:胶原蛋白/丝素蛋白双组分纳米纤维结构的制备与表征
Biomacromolecules. 2008 Apr;9(4):1106-16. doi: 10.1021/bm700875a. Epub 2008 Mar 8.
3
Green electrospun pantothenic acid/silk fibroin composite nanofibers: fabrication, characterization and biological activity.绿色静电纺丝泛酸/丝素蛋白复合纳米纤维:制备、表征及生物活性
Colloids Surf B Biointerfaces. 2014 May 1;117:14-20. doi: 10.1016/j.colsurfb.2013.12.030. Epub 2013 Dec 22.
4
Biomimetic nanofibrous scaffolds: preparation and characterization of chitin/silk fibroin blend nanofibers.仿生纳米纤维支架:几丁质/丝素蛋白共混纳米纤维的制备与表征
Int J Biol Macromol. 2006 May 30;38(3-5):165-73. doi: 10.1016/j.ijbiomac.2006.03.003. Epub 2006 Mar 7.
5
Electrospun biomimic nanofibrous scaffolds of silk fibroin/hyaluronic acid for tissue engineering.用于组织工程的丝素蛋白/透明质酸静电纺丝仿生纳米纤维支架
J Biomater Sci Polym Ed. 2012;23(9):1185-98. doi: 10.1163/092050611X576963. Epub 2012 May 11.
6
Genipin-crosslinked silk fibroin/hydroxybutyl chitosan nanofibrous scaffolds for tissue-engineering application.基因素交联丝素/羟丁基壳聚糖纳米纤维支架在组织工程中的应用。
J Biomed Mater Res A. 2010 Dec 1;95(3):870-81. doi: 10.1002/jbm.a.32895.
7
Time-resolved structural investigation of regenerated silk fibroin nanofibers treated with solvent vapor.溶剂蒸汽处理的再生丝素蛋白纳米纤维的时间分辨结构研究
Int J Biol Macromol. 2006 Mar 30;38(2):140-4. doi: 10.1016/j.ijbiomac.2006.02.009. Epub 2006 Feb 23.
8
Preparation, characterization and biocompatibility of electrospinning heparin-modified silk fibroin nanofibers.静电纺丝肝素改性丝素蛋白纳米纤维的制备、表征及生物相容性。
Int J Biol Macromol. 2011 Mar 1;48(2):345-53. doi: 10.1016/j.ijbiomac.2010.12.008. Epub 2010 Dec 21.
9
Preparation and in vivo degradation of controlled biodegradability of electrospun silk fibroin nanofiber mats.静电纺丝丝素纳米纤维垫的可控生物降解性的制备和体内降解。
J Biomed Mater Res A. 2012 Dec;100(12):3287-95. doi: 10.1002/jbm.a.34274. Epub 2012 Jun 26.
10
Effect of chitin/silk fibroin nanofibrous bicomponent structures on interaction with human epidermal keratinocytes.几丁质/丝素蛋白纳米纤维双组分结构对与人类表皮角质形成细胞相互作用的影响。
Int J Biol Macromol. 2008 May 1;42(4):324-34. doi: 10.1016/j.ijbiomac.2007.12.004. Epub 2007 Dec 25.

引用本文的文献

1
The Impact of Green Physical Crosslinking Methods on the Development of Sericin-Based Biohydrogels for Wound Healing.绿色物理交联方法对用于伤口愈合的丝胶蛋白基生物水凝胶发展的影响
Biomimetics (Basel). 2024 Aug 16;9(8):497. doi: 10.3390/biomimetics9080497.
2
Fabrication and Evaluation of Electrospun Silk Fibroin/Halloysite Nanotube Biomaterials for Soft Tissue Regeneration.用于软组织再生的电纺丝素蛋白/埃洛石纳米管生物材料的制备与评价
Polymers (Basel). 2022 Jul 25;14(15):3004. doi: 10.3390/polym14153004.
3
Higher Gene Expression Related to Wound Healing by Fibroblasts on Silk Fibroin Biomaterial than on Collagen.
与胶原蛋白相比,成纤维细胞在丝素蛋白生物材料上进行伤口愈合时基因表达更高。
Molecules. 2020 Apr 22;25(8):1939. doi: 10.3390/molecules25081939.
4
A mild process to design silk scaffolds with reduced β-sheet structure and various topographies at the nanometer scale.一种温和的方法,用于设计具有减少的β-折叠结构和纳米尺度各种形貌的丝支架。
Acta Biomater. 2015 Feb;13:168-76. doi: 10.1016/j.actbio.2014.11.016. Epub 2014 Nov 15.